insulin lispro + exenatide

This is a combination of two injectable drugs for diabetes management: - **Insulin lispro** is a rapid-acting synthetic insulin analog that mimics endogenous human insulin, promoting glucose uptake into tissues and inhibiting hepatic glucose production. It is primarily used to control hyperglycemia in type 1 and type 2 diabetes mellitus[1]. - **Exenatide** is a glucagon-like peptide-1 (GLP-1) receptor agonist. It increases glucose-dependent insulin secretion, suppresses inappropriate glucagon secretion, and slows gastric emptying, thereby improving glycemic control in type 2 diabetes mellitus[2][5]. The combination aims to leverage the complementary mechanisms of both agents—insulin replacement and incretin effect—to optimize blood sugar control in people with diabetes.